Patrick Baeuerle, See Remarks at Cullinan Oncology, Inc. (CGEM), sold 11,000 shares at $28.45 ($313K) on 2021-09-08, disclosed to the SEC on 2021-09-09.
Open-market sale of $313k CGEM by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TCRR | SELL | 2019-12-26 | $3.6M | — | Filing → |